lactic acid has been researched along with Delayed Hypersensitivity in 13 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " OBJECTIVE To review the use of injectable PLLA, specifically regarding optimal injection technique that can reduce adverse events (AEs) and enhance out comes." | 2.44 | Minimizing adverse events associated with poly-L-lactic acid injection. ( Narins, RS, 2008) |
| " Recent evidence shows that local/regional/systemic delayed adverse effects may appear with its use." | 1.35 | Late-onset immune-mediated adverse effects after poly-L-lactic acid injection in non-HIV patients: clinical findings and long-term follow-up. ( Alijotas-Reig, J; Garcia-Gimenez, V; Vilardell-Tarres, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maldonado, RA | 1 |
| LaMothe, RA | 1 |
| Ferrari, JD | 1 |
| Zhang, AH | 1 |
| Rossi, RJ | 1 |
| Kolte, PN | 1 |
| Griset, AP | 1 |
| O'Neil, C | 1 |
| Altreuter, DH | 1 |
| Browning, E | 1 |
| Johnston, L | 1 |
| Farokhzad, OC | 1 |
| Langer, R | 1 |
| Scott, DW | 1 |
| von Andrian, UH | 1 |
| Kishimoto, TK | 1 |
| Narins, RS | 1 |
| Alijotas-Reig, J | 1 |
| Garcia-Gimenez, V | 1 |
| Vilardell-Tarres, M | 1 |
| Lu, D | 1 |
| Garcia-Contreras, L | 1 |
| Muttil, P | 1 |
| Padilla, D | 1 |
| Xu, D | 1 |
| Liu, J | 1 |
| Braunstein, M | 1 |
| McMurray, DN | 1 |
| Hickey, AJ | 1 |
| Keijzer, C | 1 |
| Slütter, B | 1 |
| van der Zee, R | 1 |
| Jiskoot, W | 1 |
| van Eden, W | 1 |
| Broere, F | 1 |
| Yoshida, M | 2 |
| Babensee, JE | 1 |
| Niborski, V | 1 |
| Li, Y | 1 |
| Brennan, F | 1 |
| Lane, M | 1 |
| Torché, AM | 1 |
| Remond, M | 1 |
| Bonneau, M | 1 |
| Riffault, S | 1 |
| Stirling, C | 1 |
| Hutchings, G | 1 |
| Takamatsu, H | 1 |
| Barnett, P | 1 |
| Charley, B | 1 |
| Schwartz-Cornil, I | 1 |
| Ng, TF | 1 |
| Lavik, E | 1 |
| Keino, H | 1 |
| Taylor, AW | 1 |
| Langer, RS | 1 |
| Young, MJ | 1 |
| Sau, K | 1 |
| Reid, RH | 1 |
| McQueen, C | 1 |
| Boedeker, EC | 1 |
| Nellore, R | 1 |
| Dalal, P | 1 |
| Bhagat, HR | 1 |
| Maloy, KJ | 1 |
| Donachie, AM | 1 |
| O'Hagan, DT | 1 |
| Mowat, AM | 1 |
| Pecquet, S | 1 |
| Leo, E | 1 |
| Fritsché, R | 1 |
| Pfeifer, A | 1 |
| Couvreur, P | 1 |
| Fattal, E | 1 |
| Dutta, AS | 1 |
| Crowther, M | 1 |
| Gormley, JJ | 1 |
| Hassall, L | 1 |
| Hayward, CF | 1 |
| Gellert, PR | 1 |
| Kittlety, RS | 1 |
| Alcock, PJ | 1 |
| Jamieson, A | 1 |
| Moores, JM | 1 |
| Rees, A | 1 |
| Wood, LJ | 1 |
| Reilly, CF | 1 |
| Haworth, D | 1 |
| Matsunaga, Y | 1 |
| Wakatsuki, Y | 1 |
| Tabata, Y | 1 |
| Kawasaki, H | 1 |
| Usui, T | 1 |
| Itoh, T | 1 |
| Habu, S | 1 |
| Kita, T | 1 |
1 review available for lactic acid and Delayed Hypersensitivity
| Article | Year |
|---|---|
Minimizing adverse events associated with poly-L-lactic acid injection.
Topics: Cellulose; Cosmetic Techniques; Drug Compounding; Face; Female; Granuloma, Foreign-Body; HIV-Associa | 2008 |
12 other studies available for lactic acid and Delayed Hypersensitivity
| Article | Year |
|---|---|
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance.
Topics: Animals; Antigens; CD4-Positive T-Lymphocytes; Disease Models, Animal; Encephalomyelitis, Autoimmune | 2015 |
Late-onset immune-mediated adverse effects after poly-L-lactic acid injection in non-HIV patients: clinical findings and long-term follow-up.
Topics: Adult; Aged; Biocompatible Materials; Cohort Studies; Cosmetic Techniques; Edema; Face; Female; Foll | 2009 |
Pulmonary immunization using antigen 85-B polymeric microparticles to boost tuberculosis immunity.
Topics: Aerosols; Animals; Antigens, Bacterial; Enzyme-Linked Immunosorbent Assay; Guinea Pigs; Hypersensiti | 2010 |
PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity.
Topics: Administration, Intranasal; Antibody Formation; CD4-Positive T-Lymphocytes; Cell Proliferation; Chit | 2011 |
Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells.
Topics: Animals; Antigens, CD; Biocompatible Materials; Biomarkers; Cell Culture Techniques; Cell Shape; Cel | 2004 |
Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV.
Topics: Animals; Antibody Formation; Carrier State; Enzyme-Linked Immunosorbent Assay; Excipients; Female; F | 2006 |
Creating an immune-privileged site using retinal progenitor cells and biodegradable polymers.
Topics: Absorbable Implants; Animals; Biocompatible Materials; Cell Culture Techniques; Cell Survival; Cells | 2007 |
Intraduodenal immunization with microencapsulated CFA/II induces a delayed, anti-CFA/II, IgG antibody-secreting spleen cell response.
Topics: Animals; Antibodies, Bacterial; Antibody-Producing Cells; Antigens, Bacterial; Bacterial Proteins; B | 1995 |
Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Cell Division; Epitopes; Female; Hypersensiti | 1994 |
Oral tolerance elicited in mice by beta-lactoglobulin entrapped in biodegradable microspheres.
Topics: Animals; Biocompatible Materials; Cells, Cultured; Dose-Response Relationship, Immunologic; Female; | 2000 |
Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide.
Topics: Amino Acid Sequence; Animals; Cell Adhesion; Cell Line; CHO Cells; Cricetinae; Delayed-Action Prepar | 2000 |
Oral immunization with size-purified microsphere beads as a vehicle selectively induces systemic tolerance and sensitization.
Topics: Administration, Oral; Animals; Antigens; Drug Delivery Systems; Hypersensitivity, Delayed; Immune To | 2000 |